Aurinia Pharmaceuticals Inc (AUPH)
5.01
+0.20
(+4.16%)
USD |
NASDAQ |
Apr 19, 16:00
5.005
0.00 (0.00%)
After-Hours: 18:50
Aurinia Pharmaceuticals Free Cash Flow (Quarterly): 14.25M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.25M |
| September 30, 2023 | -13.20M |
| June 30, 2023 | -3.053M |
| March 31, 2023 | -32.18M |
| December 31, 2022 | 10.32M |
| September 30, 2022 | -15.40M |
| June 30, 2022 | -27.91M |
| March 31, 2022 | -46.82M |
| December 31, 2021 | -26.22M |
| September 30, 2021 | -40.41M |
| June 30, 2021 | -37.84M |
| March 31, 2021 | -54.72M |
| December 31, 2020 | 1.021M |
| September 30, 2020 | -32.70M |
| June 30, 2020 | -22.71M |
| March 31, 2020 | -22.82M |
| December 31, 2019 | -25.44M |
| September 30, 2019 | -11.80M |
| June 30, 2019 | -13.28M |
| March 31, 2019 | -13.17M |
| December 31, 2018 | -13.64M |
| September 30, 2018 | -11.33M |
| June 30, 2018 | -12.32M |
| March 31, 2018 | -14.40M |
| December 31, 2017 | -8.94M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.525M |
| June 30, 2017 | -14.01M |
| March 31, 2017 | -9.719M |
| December 31, 2016 | -4.277M |
| September 30, 2016 | -4.192M |
| June 30, 2016 | -5.048M |
| March 31, 2016 | -5.221M |
| December 31, 2015 | -4.838M |
| September 30, 2015 | -5.227M |
| June 30, 2015 | -3.719M |
| March 31, 2015 | -4.032M |
| December 31, 2014 | -3.369M |
| September 30, 2014 | -4.045M |
| June 30, 2014 | -4.229M |
| March 31, 2014 | -5.355M |
| December 31, 2013 | -2.572M |
| September 30, 2013 | -1.521M |
| June 30, 2013 | -0.428M |
| March 31, 2013 | -0.207M |
| December 31, 2012 | -0.7887M |
| September 30, 2012 | -1.255M |
| June 30, 2012 | -2.722M |
| March 31, 2012 | -1.820M |
| December 31, 2011 | -1.327M |
| September 30, 2011 | -1.160M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-54.72M
Minimum
Mar 2021
14.25M
Maximum
Dec 2023
-21.10M
Average
-22.82M
Median
Mar 2020
Free Cash Flow (Quarterly) Benchmarks
| Lexaria Bioscience Corp | -0.6766M |
| Acasti Pharma Inc | -1.892M |
| Edesa Biotech Inc | -1.406M |
| Xenon Pharmaceuticals Inc | -35.54M |
| ESSA Pharma Inc | -6.787M |